Press release
RNA Interference (RNAi) Drug Delivery Market Trends, Share, Driving Factors, Opportunity and Forecast 2022-2027
RNA interference (RNAi) drug delivery is a fundamental cellular mechanism that studies gene functions in eukaryotic organisms. It is also essential for silencing gene expressions for the development of new drugs. RNAi is considered a potential approach for treating various pathologic conditions, including cardiovascular diseases (CVDs), viral infections and cancer. It includes nonviral delivery of siRNA and viral delivery of shRNA that is used across various preclinical models and molecular targets for its transformational effect on modern medicine.
Request for a PDF sample of this report: https://www.imarcgroup.com/rna-interference-drug-delivery-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
RNA Interference (RNAi) Drug Delivery Market Trends:
The global RNA interference (RNAi) drug delivery market is primarily driven by the increasing number of academic research institutes performing RNA therapeutic studies. The rising prevalence of chronic diseases, such as cardiac defects and cancer, is also propelling the growth of the market. In recent years, the demand for RNAi has escalated due to its high level of specificity, minor side effects, and ease of synthesis. Besides this, siRNA or microRNAs (miRNA) helps in developing personalized medicines and identifying altered cellular molecules and metabolites. Furthermore, advancements in the field of nanotechnology that facilitate nanoparticle drug delivery and the overall improvements in the healthcare infrastructure are expected to provide a positive impact on the market.
RNA Interference (RNAi) Drug Delivery Market 2022-2027 Competitive Analysis and Segmentation:
Competitive Landscape with Key Players:
The competitive landscape of the global RNA interference (RNAi) drug delivery market has also been examined along with the profiles of the key players.
Some of these key players include:
Alnylam Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
CureVac AG
Dicerna Pharmaceuticals Inc.
Gradalis Inc.
Ionis Pharmaceuticals Inc
Merck & Co. Inc.
Moderna Inc.
Quark Pharmaceuticals Inc. (SBI ALApharma Co. Limited)
Silence Therapeutics Plc
Sirnaomics Inc.
Key Market Segmentation:
The report has segmented the RNA interference (RNAi) drug delivery market based on application, technology, and region.
Breakup by Application:
Infectious Disease
Cardiology
Oncology
Neurology
Ophthalmology
Urology
Metabolic Disorders
Others
Breakup by Technology:
Nanoparticle Drug Delivery
Pulmonary Drug Delivery
Nucleic Acid Drug Delivery
Aptamer Drug Delivery
Breakup by Region:
North America (United States, Canada)
Europe (Germany, France, United Kingdom, Italy, Spain, Others)
Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
Latin America (Brazil, Mexico, Others)
Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, South Africa, Others)
Ask Analyst for Customization and Explore full report with TOC & List of Figures: https://www.imarcgroup.com/request?type=report&id=2758&flag=C
Key highlights of the report:
Market Performance (2016-2021)
Market Outlook (2022-2027)
Market Trends
Market Drivers and Success Factors
Impact of COVID-19
Value Chain Analysis
Comprehensive mapping of the competitive landscape
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
Related Reports by IMARC Group:
Multiple Sclerosis Therapies Market: https://bit.ly/3rzqFXH
Portable Medical Ventilators Market: https://bit.ly/3EgRNCq
Nucleic Acid Labelling Market: https://bit.ly/3V4i4Kb
Latin America Generic Drug Market: https://bit.ly/3T0mI9Z
North Africa Generic Drug Market: https://bit.ly/3SGXVIs
Contact Us:
IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release RNA Interference (RNAi) Drug Delivery Market Trends, Share, Driving Factors, Opportunity and Forecast 2022-2027 here
News-ID: 2758665 • Views: …
More Releases from IMARC Group
Top 15 Leading Commercial Refrigeration Manufacturers in The World 2024
Commercial Refrigeration Companies
Top commercial refrigeration companies are investing in research and development (R&D) to introduce advanced products that offer enhanced efficiency, better temperature management, and reduced environmental impact. Additionally, companies are integrating internet of things (IoT) technology to allow for real-time monitoring and management of refrigeration systems, which helps in reducing operational costs and improving food safety by maintaining optimal conditions. Key players are developing systems that use less power…
Top Generative AI Companies in The World 2024
Global Generative AI Companies
Generative artificial intelligence (AI), also known as generative adversarial networks (GANs) or generative models, works by learning the patterns and features of a dataset and then generating new data instances that resemble the original data. It can create new content, such as images, videos, text, and music, which can be useful in fields like art, design, and entertainment. It can learn the distribution of normal data and…
Vietnam Water Treatment Chemicals Market Share, Demand, Industry Growth And Fore …
IMARC Group's report titled "Vietnam Water Treatment Chemicals Market Report by Type (Coagulants and Flocculants, Corrosion Inhibitors, Scale Inhibitors, Biocides and Disinfectants, Chelating Agents, Anti-Foaming Agents, PH Adjusters and Stabilizers, and Others), End User (Municipal, Power, Oil and Gas, Mining, Chemicals, Food and Beverage, Pulp and Paper, and Others), and Region 2024-2032" Vietnam water treatment chemicals market is projected to exhibit a growth rate (CAGR) of 4.99% during 2024-2032.
The Vietnam water…
Furniture Market Size, Sales Revenue, Industry Growth, Forecast 2024-2032
IMARC Group, a leading market research company, has recently releases report titled "Furniture Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032" The global furniture market size reached US$ 660.5 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 701.7 Billion by 2032.
Request For Sample Copy of Report For More Detailed Market insight: https://www.imarcgroup.com/furniture-market/requestsample
Factors Affecting the Growth of the Furniture Industry:
Rapid Urbanization:
Urban areas are leading…
More Releases for RNA
Global RNA Analysis/Transcriptomics Market Report
The Global RNA Analysis / Transcriptomics Market is projected to expand at a CAGR of 12.5% during the forecast period, to hit USD 8.1 Billion by 2026, according to a recent market report compiled by Global Market Estimates. Due to the rising need for personalized medicines, the demand for RNA Analysis / Transcriptomics is expected to raise the market demand.
Browse 156 Market Data Tables and 112 Figures spread through 175…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
Senior experts from Exicure, Roche, GSK, BioNTech RNA Pharmaceuticals & MiNA The …
With less than 4 weeks until SMi’s 10th annual RNA Therapeutics event (http://www.therapeutics-rna.com/openpr) opens its doors in London, UK next month, registration will soon be closing and delegate places are becoming increasingly limited.
Over the course of 2 focused days, attendees will be able to have an exclusive look into key developments in oligonucleotide therapeutics, mRNA technology, delivery mechanisms, and much more, led by industry leaders, scientific pioneers, and academics exploring…
RNA Therapy Improves Vision in Child Blindness, hear more about recent developme …
SMi Reports: In light of recent developments in the field of RNA Therapy, SMi’s 10th Annual RNA Therapeutics is set to deliver the latest advancements in February this year.
Leber congenital amaurosis (LCA), one of the most common causes of blindness in children, has been the subject of successful RNA therapy as researchers at the University of Pennsylvania recently published new data showing the success of the new therapy which improved…
New Confirmed Delegates & Speakers for RNA Therapeutics
SMi are thrilled to welcome Dr. James Hamilton, Vice President, Head of Clinical Development, Arrowhead Pharmaceuticals onto the speaker panel RNA Therapeutics 2018!
Dr. James Hamilton is currently responsible for all aspects of clinical trial design, implementation and execution. In this role, Dr. Hamilton managed the ARC-520 and ARC-AAT global programs through Phase 2 of development. Previously, Dr. Hamilton was Medical Director and Head of Corporate Development at Arrowhead. He led…
Introducing the 9th Annual RNA Therapeutics 2018
As the requirement for targeted solutions for chronic diseases continues to grow, the interest of pharmaceutical and biotech companies has increasingly focused towards RNA therapeutics, such that by 2020, the RNA Therapeutics Market is predicted to attain $1.2 billion.
One of the main challenges in RNA Therapeutics continues to be bridging the gap between in-vivo and in-vitro models, hear key case studies on the development on the latest delivery systems and…
